Cargando…

Dostarlimab: A breakthrough in the field of oncology

Of the 19 million cancer cases reported worldwide in 2020, colorectal cancer (CRC) has a 10% prevalence and 9.4% mortality. A critical lack of cancer treatment facilities in third-world countries like Pakistan where a significant prevalence of CRC has been detected. The five FDA-approved drugs used...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hussain, Hassan ul, Burney, Muhammad Husban, Rehan, Syeda Tayyaba, Hasan, Mohammad Mehedi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9422050/ https://www.ncbi.nlm.nih.gov/pubmed/36045764 http://dx.doi.org/10.1016/j.amsu.2022.104046

Ejemplares similares

Monkeypox virus: A future scourge to the Pakistani Healthcare system
por: Mansoor, Hussain, et al.
Publicado: (2022)

Poliovirus returns to Pakistan: A rising concern
por: Imran, Laiba, et al.
Publicado: (2022)

Ocular manifestations: A novel association of Monkeypox virus outbreak in 2022
por: Alam, Muhammad Sharjeel, et al.
Publicado: (2023)

Serious absenteeism amongst Pakistani school and university girls during menstruation: Is this a neglected threat to already deteriorating girls' education in the country?
por: Rehan, Syeda Tayyaba, et al.
Publicado: (2022)

Jemperli (Dostarlimab-gxly): An unprecedented cancer trial
por: Ali, Eman, et al.
Publicado: (2022)

Dostarlimab, a boon or a healthcare burden- too early to acertain!
por: Fatima, Nabeela, et al.
Publicado: (2022)

Increasing incidence of unsafe abortions among female Pakistani university students: Lack of awareness and social stigma proves to be fatal
por: Imran, Laiba, et al.
Publicado: (2022)

Two-way association between alopecia areata and sleep disorders: A systematic review of observational studies
por: Rehan, Syeda Tayyaba, et al.
Publicado: (2022)

Dostarlimab: A Review
por: Costa, Bárbara, et al.
Publicado: (2022)

Outbreak of Monkeypox in South East Asia; Spotlight on Bangladesh, Pakistan and India
por: Khatri, Govinda, et al.
Publicado: (2022)

FDA approves Ruxolitinib (Opzelura) for Vitiligo Therapy: A breakthrough in the field of dermatology
por: Sheikh, Ayesha, et al.
Publicado: (2022)

An Integrated Analysis of Dostarlimab Immunogenicity
por: Lu, Sharon, et al.
Publicado: (2021)

Mucormycosis infection in hematopoietic stem cell transplant patients: A serious threat
por: Mir, Syeda Lamiya, et al.
Publicado: (2022)

Perioperative selenium administration in cardiac surgery patients, a way out to reduce post surgical adversities? A meta analysis
por: Rehan, Syeda Tayyaba, et al.
Publicado: (2023)

Low‐intensity focused ultrasound, a novel approach to epilepsy treatment in developing countries
por: Afif, Sadaf, et al.
Publicado: (2022)

The revival of telemedicine in the age of COVID-19: Benefits and impediments for Pakistan
por: Farooqi, Maheera, et al.
Publicado: (2021)

Dostarlimab/tozinameran: Various toxicities: case report
Publicado: (2022)

Dostarlimab: The miracle drug for the treatment of colorectal cancer
por: Shuvo, Pollob Ahmed, et al.
Publicado: (2022)

Voxelotor versus other therapeutic options for sickle cell disease: Are we still lagging behind in treating the disease?
por: Tayyaba Rehan, Syeda, et al.
Publicado: (2022)

Programmed death ligand 1, poly adenosine diphosphate ribose polymerase, and vascular endothelial growth factor receptor inhibition: a potential combination regimen for targeting triple-negative breast cancer?
por: Abdul Wahid, Maryam, et al.
Publicado: (2023)

Lumasiran: a potential therapy for the management of primary hyperoxaluria type 1? An editorial
por: Ghani, Sundus A., et al.
Publicado: (2023)

Routine Pap smear screening in Pakistan: A current perspective
por: Bhimani, Simran, et al.
Publicado: (2022)

Pyruvate kinase activator: A major breakthrough in the world of Hematology
por: Iqbal, Amna, et al.
Publicado: (2022)

Statins: Masked anti-epileptic warriors
por: Khatri, Govinda, et al.
Publicado: (2022)

CABG versus PCI: What is the optimal strategy for multi-vessel disease?
por: Kumar, Ayush, et al.
Publicado: (2022)

Hydrochlorothiazide: A savior to the heart or a foe to the skin?
por: Kumar, Ayush, et al.
Publicado: (2022)

Bullous pemphigoid following COVID-19 vaccine: An autoimmune disorder
por: Aashish, et al.
Publicado: (2022)

Global Monkeypox Virus Outbreak 2022: A Bibliometric Analysis
por: Rehan, Syeda Tayyaba, et al.
Publicado: (2023)

COVID-19 vaccine – Long term immune decline and breakthrough infections
por: Khoury, Johad, et al.
Publicado: (2021)

Breakthrough infections and acceptance of COVID-19 vaccine boosters: A survey analysis
por: Stevens, Christina W., et al.
Publicado: (2023)

Acetaminophen: A hazard to immunotherapy
por: Najeebullah, et al.
Publicado: (2022)

Dostarlimab: From preclinical investigation to drug approval and future directions
por: Cicala, Carlo Maria, et al.
Publicado: (2023)

Association between vitamin D levels in early pregnancy and gestational diabetes mellitus: A systematic review and meta-analysis
por: Fatima, Kaneez, et al.
Publicado: (2022)

Factors associated with loss of motivation and hesitation to work amongst frontline health care providers during the COVID-19 pandemic: A cross-sectional survey from a developing country
por: Malik, Mehreen, et al.
Publicado: (2022)

Dostarlimab as a Miracle Drug: Rising Hope against Cancer Treatment
por: Singh, Vanshikha, et al.
Publicado: (2022)

Association of adverse childhood experiences with adulthood multiple sclerosis: A systematic review of observational studies
por: Rehan, Syeda Tayyaba, et al.
Publicado: (2023)

Intravascular lithotripsy with peripheral Shockwave catheter – a breakthrough in calcified carotid artery stenosis treatment
por: Misztal, Marcin, et al.
Publicado: (2020)

Metallic nanoparticle-coated sutures: a breakthrough in the field of surgery
por: Khan, Abdul Moiz, et al.
Publicado: (2023)

Genomic profiles of vaccine breakthrough SARS-CoV-2 strains from Odisha, India
por: Ghosh, Arup, et al.
Publicado: (2022)

Breakthrough infections with the SARS-CoV-2 Delta variant: vaccinations halved transmission risk
por: Hsu, L., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_saa3na62q7fsnfh4gu5cde1hf7